This presentation will review clinical assessments for evaluating the integrity of the intestinal barriers and testing to determine the presence of systemic bacterial toxins and predictive antibodies for cardiovascular disease. Detailed clinical approaches and treatment protocols for restoring damaged barriers and eliminating gut dysbiosis will also be discussed.